INNATE PHARMA SA-SPONS ADR (IPHA) Stock Analyst Ratings
NASDAQ:IPHA - Nasdaq - US45781K2042 - ADR
ChartMill assigns a Buy % Consensus number of 78% to IPHA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.46. This target is 208.69% above the current price.
IPHA was analyzed by 10 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about IPHA.
In the previous month the buy percentage consensus was at a similar level.
IPHA was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-24 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-11-15 | SVB Leerink | Maintains | Outperform |
| 2022-09-16 | Citigroup | Maintains | Buy |
| 2022-08-02 | SVB Leerink | Maintains | Outperform |
| 2022-05-11 | SVB Leerink | Maintains | Outperform |
| 2021-09-17 | SVB Leerink | Maintains | Outperform |
| 2021-09-03 | SVB Leerink | Upgrade | Market Perform -> Outperform |
| 2021-09-02 | SVB Leerink | Upgrade | Market Perform -> Outperform |